Background: Understanding the reliability and validity of field-based mobility and performance tests used within the wheelchair sports of basketball (WCB), rugby (WCR) and tennis (WCT) can assist in understanding an athletes' physiological state, training effects, and/or assist with optimising their wheelchair-user interface.
Purpose: To examine, evaluate and synthesize current aerobic and anaerobic field-based mobility and performance tests used in WCB, WCR and WCT.
Methods: A systematic search was performed according to PRISMA guidelines. Studies were included if they investigated performance tests in WCB, WCR and WCT and reported reliability.
Results: Twenty-one studies covering 45 mobility/performance tests were included (anaerobic, = 35; aerobic, = 10), with agility and repeated sprints ( = 13) being the most common, followed by linear-sprints ( = 11). Repeated sprint ability ( = 2) and submaximal field-tests ( = 2) were the least frequent. Intra-class correlations among all tests ranged from 0.62 to 0.99, with agility and repeated sprints being 0.65-0.98, followed by values of 0.62-0.99 for linear-sprint, 0.96-0.99 for repeated sprints and 0.85-0.97 for submaximal field-tests.
Conclusion: The most frequently measured performance tests were anaerobic tests focusing on agility and repeated sprints. Given the low number of aerobic tests in WCB, WCR and WCT, future research should focus on reliable and valid ways to measure and track performance.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/02640414.2023.2259726 | DOI Listing |
Eur J Epidemiol
January 2025
Department of Neurobiology, Care Sciences and Society, Division of Family Medicine and Primary Care, Karolinska Institutet, Stockholm, Sweden.
The Stockholm Early Detection of Cancer Study (STEADY-CAN) cohort was established to investigate strategies for early cancer detection in a population-based context within Stockholm County, the capital region of Sweden. Utilising real-world data to explore cancer-related healthcare patterns and outcomes, the cohort links extensive clinical and laboratory data from both inpatient and outpatient care in the region. The dataset includes demographic information, detailed diagnostic codes, laboratory results, prescribed medications, and healthcare utilisation data.
View Article and Find Full Text PDFAm J Sports Med
January 2025
Midwest Orthopaedics at Rush University Medical Center, Chicago, Illinois, USA.
Background: Mismatch between osteochondral allograft (OCA) donor and recipient sex has been shown to negatively affect outcomes. This study accounts for additional donor variables and clinically relevant outcomes.
Purpose: To evaluate whether donor sex, age, donor-recipient sex mismatch, and duration of graft storage affect clinical outcomes and failure rates after knee OCA transplantation.
Ophthalmol Ther
January 2025
Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg, Saar, Germany.
Introduction: Congenital aniridia is increasingly recognized as part of a complex syndrome with numerous ocular developmental anomalies and non-ocular systemic manifestations. This requires comprehensive care and treatment of affected patients. Our purpose was to analyze systemic diseases in patients with congenital aniridia within the Homburg Aniridia Registry.
View Article and Find Full Text PDFEur J Hum Genet
January 2025
Institute of Bioinformatics, International Technology Park, Bangalore, 560066, India.
Mitochondrial membrane protein-associated neurodegeneration (MPAN) is a rare neurodegenerative disorder characterized by spastic paraplegia, parkinsonism and psychiatric and/or behavioral symptoms caused by variants in gene encoding chromosome-19 open reading frame-12 (C19orf12). We present here seven patients from six unrelated families with detailed clinical, radiological, and genetic investigations. Childhood-onset patients predominantly had a spastic ataxic phenotype with optic atrophy, while adult-onset patients were presented with cognitive, behavioral, and parkinsonian symptoms.
View Article and Find Full Text PDFHum Genet
January 2025
Division of Hearing and Balance Research, National Institute of Sensory Organs, NHO Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-Ku, Tokyo, 152-8902, Japan.
There are hundreds of rare syndromic diseases involving hearing loss, many of which are not targeted for clinical genetic testing. We systematically explored the genetic causes of undiagnosed syndromic hearing loss using a combination of whole exome sequencing (WES) and a phenotype similarity search system called PubCaseFinder. Fifty-five families with syndromic hearing loss of unknown cause were analyzed using WES after prescreening of several deafness genes depending on patient clinical features.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!